Browse result page of THPdb

The total number entries retrieved from this search are 178

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1415	ThPPIDTh1069	NamePegvisomant	Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view	Length191	Functional ClassificationIIa	DiseaseHormonal	BrandSOMAVERT	CompanyPfizer	Physical AppearanceSterile, white lyophilized powderÂÂÂ	Route of AdministartionSubcutaneous Injection	CategoryHormone Replacement Agents	TargetB-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1419	ThPPIDTh1070	NameBotulinum Toxin Type A	Peptide SequenceMPFVNKQFNYKDPVNGVDIA Full view	Length1296	Functional ClassificationIc	DiseaseNeurological Disorder	BrandBOTOXÂÂÂ	CompanyAllergan	Physical AppearanceSterile, vacuum-dried purified botulinum toxin type A, produced from fermentation of Hall strainClostridium botulinum type A	Route of AdministartionIntramuscular, intradetrusor and intradermal use	CategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents	TargetGrowth hormone receptor
ID1420	ThPPIDTh1070	NameBotulinum Toxin Type A	Peptide SequenceMPFVNKQFNYKDPVNGVDIA Full view	Length1296	Functional ClassificationIc	DiseaseNeurological Disorder	BrandDysport	CompanyIpsen Pharmaceuticals	Physical AppearanceSterile vial for reconstitution	Route of AdministartionIntramuscular Injection	CategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents	TargetGrowth hormone receptor
ID1421	ThPPIDTh1070	NameBotulinum Toxin Type A	Peptide SequenceMPFVNKQFNYKDPVNGVDIA Full view	Length1296	Functional ClassificationIc	DiseaseNeurological Disorder	BrandXeomin	CompanyMERZ AESTHETICS	Physical AppearanceSterile white to off-white lyophilized powder after reconstitution with preservative-free 0.9% Saline for Injection.	Route of AdministartionIntramuscular Injection	CategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents	TargetGrowth hormone receptor
ID1434	ThPPIDTh1074	NameAlglucerase	Peptide SequenceARPCIPKSFGYSSVVCVCNA Full view	Length497	Functional ClassificationIa	DiseaseMetabolic	BrandCeredase	CompanyGenzyme Corporation	Physical AppearanceClear sterile non-pyrogenic solution of alglucerase in a citrate buffered solution	Route of AdministartionIntravenous injection	CategoryEnzyme Replacement Agents	TargetPlasminogen,Proteinase-activated receptor 1
ID1435	ThPPIDTh1075	NameCapromab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIV	DiseaseCancer	BrandProstaScint	CompanyJazz Pharmaceuticals, Inc.	Physical AppearanceSterile, pyrogen-free, clear, colorless solution that may contain some translucent particles.	Route of AdministartionIntravenous injection	CategoryIndicators, Reagents and Diagnostic Agents	TargetCAMPATH-1 antigen,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1447	ThPPIDTh1080	NameChoriogonadotropin Alfa	Peptide SequenceAlpha chain: APDVQDC Full view	Length237	Functional ClassificationIb	DiseaseHormonal	BrandChoriogonadotropin alfa	CompanyEmd serono inc, Ferring pharmaceuticals inc, App pharmaceuticals llc, Bel mar laboratories inc, Bris	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryFertility Agents and Gonadotropins	TargetIntegrin alpha-L, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a, Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c
ID1451	ThPPIDTh1082	NameFilgrastim	Peptide SequenceMTPLGPASSLPQSFLLKCLE Full view	Length175	Functional ClassificationIb	DiseaseImmunological	BrandN.A.	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryImmunosuppressive Agents, Antineutropenic Agents and Hematopoietic Agents	TargetLutropin-choriogonadotropic hormone receptor,Follicle-stimulating hormone receptor
ID1454	ThPPIDTh1084	NameBecaplermin	Peptide SequenceSLGSLTIAEPAMIAECKTRT Full view	Length109	Functional ClassificationIb	DiseaseCardiac	BrandREGRANEX	CompanyOMJ Pharmaceuticals, Inc. San German, Puerto Rico	Physical AppearanceGel: 0.01 %; clear, colorless to straw-colored gel	Route of AdministartionExternal use only	CategoryAngiogenesis Inducing Agents	TargetT-cell surface glycoprotein CD1a,Major histocompatibility complex class I-related gene protein,Integrin alpha-L,T-lymphocyte activation antigen CD86,Low affinity immunoglobulin gamma Fc region receptor II-b,T-cell surface glycoprotein CD4,Integrin beta-1,Integrin alpha-V,Integrin beta-3
ID1456	ThPPIDTh1086	NameInterferon Alfa-2B, Recombinant	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseImmunological	BrandINTRON® A	CompanyMerck	Physical AppearancePowder or solution	Route of AdministartionIntramuscular, Subcutaneous, Intralesional, or Intravenous injection	CategoryImmunosuppressive Agents	TargetGranulocyte colony-stimulating factor receptor,Neutrophil elastase, Coagulation factor X,Coagulation factor XI,Coagulation factor VII,Coagulation factor VIII,Prothrombin,Prolow-density lipoprotein receptor-related protein 1,Vitamin K-dependent gamma-carboxylase, Platelet-derived growth factor receptor beta,Platelet-derived growth factor receptor alpha,Alpha-2-macroglobulin
ID1460	ThPPIDTh1087	NameOxytocin	Peptide SequenceCYIQNCPLG Full view	Length9	Functional ClassificationIb	DiseaseHormonal	BrandPitocin	CompanyJHP Pharmaceuticals	Physical AppearanceSterile, clear, colorless aqueous solution of synthetic oxytocin	Route of AdministartionIntravenous infusion	CategoryOxytocics, Anti-tocolytic Agents and Labor Induction Agents	TargetInterferon alpha/beta receptor 2,Interferon alpha/beta receptor 1, Globotriaosylceramide
ID1462	ThPPIDTh1088	NameEnfuvirtide	Peptide SequenceYTSLIHSLIEESQNQQEKNE Full view	Length36	Functional ClassificationIIa	DiseaseInfectious	Brand`FUZEON	CompanyTrimeris, Roche	Physical AppearanceWhite to off-white, sterile, lyophilized powder.	Route of AdministartionSubcutaneous injection	CategoryHIV Fusion Inhibitors	TargetOxytocin receptor,Oxytocin-neurophysin 1, Envelope glycoprotein
ID1466	ThPPIDTh1090	NameDaclizumab	Peptide SequenceQVQLVQSGAEVKKPGSSVKV Full view	Length674	Functional ClassificationIIa	DiseaseImmunologicals	BrandZenapax	CompanyRoche	Physical AppearanceClear, sterile, colorless concentrate for further dilution and intravenous administration	Route of AdministartionIntravenous injection	CategoryImmunosuppressive Agents	TargetFusion glycoprotein F0,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1468	ThPPIDTh1091	NameBevacizumab	Peptide SequenceDIQMTQSPSSLSASVGDRVT Full view	Length214	Functional ClassificationIIa	DiseaseCardiac	BrandAvastin	CompanyGenentech	Physical AppearanceSlightly opalescent, colorless to pale brown, sterile, pH 6.2 solution for intravenous infusion	Route of AdministartionIntravenous infusion	CategoryAngiogenesis Inhibitors	TargetInterleukin-2 receptor subunit alpha,Interleukin-2 receptor subunit beta,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1470	ThPPIDTh1092	NameArcitumomab	Peptide SequenceHeavy chain 1EVKLVES Full view	Length1310	Functional ClassificationIIb	DiseaseCancer	BrandCEA-Scan	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryDiagnostic Agents	TargetVascular endothelial growth factor A,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Carcinoembryonic antigen-related cell adhesion molecule 1
ID1474	ThPPIDTh1094	NamePanitumumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseCancer	BrandVectibix	CompanyAmgen Inc	Physical AppearanceSterile, colorless, pH 5.6 to 6.0 liquid for intravenous (IV) infusion, which may contain a small amount of visible translucent-to-white, amorphous, proteinaceous, panitumumab particulates	Route of AdministartionN.A.	CategoryN.A.	TargetEpidermal growth factor receptor
ID1477	ThPPIDTh1097	NameAlglucosidase Alfa	Peptide SequenceAHPGRPRAVPTQCDVPPNSR Full view	Length882	Functional ClassificationIc	DiseaseMetabolic	BrandLUMIZYME	CompanyGenzyme	Physical AppearanceSterile, nonpyrogenic, white to off-white, lyophilized cake or powder for reconstitution with 10.3 Ml Sterile Water for Injection, USP	Route of AdministartionIntravenous infusion	CategoryEnzyme Replacement Agents	TargetCation-dependent mannose-6-phosphate receptor,Glycogen
ID1478	ThPPIDTh1098	NameExenatide	Peptide SequenceHGEGTFTSDLSKQMEEEAVR Full view	Length39	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandBYETTA	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryHypoglycemic Agents	TargetGlucagon-like peptide 1 receptor
ID1479	ThPPIDTh1098	NameExenatide	Peptide SequenceHGEGTFTSDLSKQMEEEAVR Full view	Length39	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandBYDUREON	CompanyAmylin Pharmaceuticals	Physical AppearanceWhite to off-white powder that is available in a dosage strength of 2 mg exenatide per vial or per pen	Route of AdministartionN.A.	CategoryHypoglycemic Agents	TargetGlucagon-like peptide 1 receptor
ID1480	ThPPIDTh1099	NameMecasermin	Peptide SequenceGPETLCGAELVDALQFVCGD Full view	Length70	Functional ClassificationIb	DiseaseHormonal	BrandN.A.	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryN.A.	TargetInsulin-like growth factor 1 receptor,Insulin-like growth factor-binding protein 3,Insulin receptor,Cation-independent mannose-6-phosphate receptor
ID1482	ThPPIDTh1100	NamePramlintide	Peptide SequenceKCNTATCATQRLANFLVHSS Full view	Length37	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandSymlin	CompanyAmylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca)	Physical AppearanceClear, isotonic, sterile solution	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetCalcitonin receptor,Receptor activity-modifying protein 1,Receptor activity-modifying protein 2,Receptor activity-modifying protein 3
ID1500	ThPPIDTh1103	NameCosyntropin	Peptide SequenceACTH(1-24): SYSM Full view	Length24	Functional ClassificationIV	DiseaseHormonal	BrandCortrosyn	CompanyAmphastar Pharmaceuticals	Physical AppearanceN.A.	Route of AdministartionIntravenous injection, Intravenous infusion, Intramuscular injection	CategoryHormones and Diagnostic Agents	TargetAdrenocorticotropic hormone receptor
ID1502	ThPPIDTh1105	NameInsulin Aspart	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovoLog	CompanyNovo Nordisk	Physical AppearanceSterile, aqueous, clear, and colorless solution	Route of AdministartionSubcutaneous injection, Intravenous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1503	ThPPIDTh1105	NameInsulin Aspart	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovoLog Mix 50/50	CompanyNovo Nordisk	Physical AppearanceUniform, white, sterile suspension that contains insulin aspart	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1504	ThPPIDTh1105	NameInsulin Aspart	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovoLog Mix 70/30	CompanyNovo Nordisk	Physical AppearanceUniform, white, sterile suspension that contains insulin aspart 100 Units/mL.	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1511	ThPPIDTh1106	NameInsulin Detemir	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandLEVEMIR	CompanyNovo Nordisk	Physical AppearanceClear, colorless, aqueous, neutral sterile solution	Route of AdministartionSubcutaneous injection	CategoryAntidiabetic Agents	TargetInsulin receptor
ID1520	ThPPIDTh1107	NameInsulin Glulisine	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandAPIDRA	Companysanofi-aventis	Physical AppearanceSterile, aqueous, clear, and colorless solution	Route of AdministartionN.A.	CategoryAntidiabetic Agents	TargetInsulin receptor
ID1532	ThPPIDTh1111	NameDefibrotide	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIb	DiseaseImmunological	BrandNoravid	Companysanofi-aventis	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntithrombins	TargetAdenosine receptor A1,Adenosine receptor A2a,Adenosine receptor A2b
ID1535	ThPPIDTh1114	NamePreotact	Peptide SequenceParathyroid hormone: Full view	Length84	Functional ClassificationIb	DiseaseOsteological	BrandPreotactÂÂÂ	CompanyNycomed	Physical AppearanceN.A.	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetParathyroid hormone/parathyroid hormone-related peptide receptor,Parathyroid hormone 2 receptor
ID1550	ThPPIDTh1119	NameTocilizumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological	BrandACTEMRA	CompanyGenentech	Physical AppearanceSterile, preservative-free solution, colorless to pale yellow liquid, with a pH of about 6.5	Route of AdministartionIntravenous infusion, Subcutaneous injection	CategoryN.A.	TargetInterleukin-6 receptor subunit alpha
ID1556	ThPPIDTh1120	NameTeriparatide	Peptide SequenceParathyroid hormone Full view	Length34	Functional ClassificationIb	DiseaseOsteological	BrandForteo	CompanyEli Lilly and Company	Physical AppearanceSterile, colorless, clear, isotonic solution	Route of AdministartionSubcutaneous injection	CategoryBone Density Conservation Agents	TargetParathyroid hormone/parathyroid hormone-related peptide receptor
ID1560	ThPPIDTh1121	NamePertuzumab	Peptide Sequencelight chain DIQMTQSP Full view	Length664	Functional ClassificationIIIc	DiseaseCancer	BrandPerjeta	CompanyGenentech	Physical AppearanceSterile, clear to slightly opalescent, colorless to pale brown liquid	Route of AdministartionIntravenous infusion	CategoryMonoclonal antibodies	TargetReceptor tyrosine-protein kinase erbB-2
ID1562	ThPPIDTh1122	NameRilonacept	Peptide Sequencerilonacept|Homo sapi Full view	Length880	Functional ClassificationIIa	DiseaseImmunological	BrandArcalyst	CompanyRegeneron Pharmaceuticals	Physical AppearanceSterile, white to off-white, lyophilized powder	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetInterleukin-1 beta,Interleukin-1 alpha,Interleukin-1 receptor antagonist protein
ID1576	ThPPIDTh1124	NameLiraglutide	Peptide SequenceHAEGTFTSDVSSYLEGQAAK Full view	Length33	Functional ClassificationIb	DiseaseHormonal	BrandSaxenda	CompanyNovo Nordisk	Physical AppearanceClear, colorless solution	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetGlucagon-like peptide 1 receptor
ID1577	ThPPIDTh1124	NameLiraglutide	Peptide SequenceHAEGTFTSDVSSYLEGQAAK Full view	Length33	Functional ClassificationIb	DiseaseHormonal	BrandVictoza	CompanyNovo Nordisk	Physical AppearanceClear, colorless solution.	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetGlucagon-like peptide 1 receptor
ID1600	ThPPIDTh1127	NameBuserelin	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIIc	DiseaseCancer/Hormonal	BrandSuprecur (Nasal Spray Solution)	CompanySanofi-Aventis	Physical Appearance150 micrograms Nasal Spray Solution	Route of AdministartionNasal spray	CategoryN.A.	TargetLutropin-choriogonadotropic hormone receptor,Gonadotropin-releasing hormone receptor
ID1601	ThPPIDTh1127	NameBuserelin	Peptide SequencepGlu-His-Trp-Ser-Tyr Full view	Length9	Functional ClassificationIIIc	DiseaseCancer/Hormonal	BrandSuprecur (injection)	CompanySanofi-Aventis	Physical Appearance1mg/ml Injection	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetLutropin-choriogonadotropic hormone receptor,Gonadotropin-releasing hormone receptor
ID1603	ThPPIDTh1129	NameTesamorelin	Peptide SequenceYADAIFTNSYRKVLGQLSAR Full view	Length44	Functional ClassificationIb	DiseaseHormonal	BrandEgrifta	CompanyTheratechnologies	Physical AppearanceSterile, white to off-white, preservative-free lyophilized powder	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetGrowth hormone-releasing hormone receptor
ID1604	ThPPIDTh1130	NameBrentuximab Vedotin	Peptide SequenceHeavy chain:QIQLQQSG Full view	Length664	Functional ClassificationIIb	DiseaseCancer	BrandAdcetris	CompanySeattle Genetics	Physical AppearanceSterile, white to off-white, preservative-free lyophilized cake or powder in single-use vials.	Route of AdministartionIntravenous infusion	CategoryN.A.	TargetTumor necrosis factor receptor superfamily member 8
ID1624	ThPPIDTh1137	NameTeduglutide	Peptide SequenceHGDGSFSDEMNTILDNLAAR Full view	Length33	Functional ClassificationIa	DiseaseMalabsorption disorder	BrandGattex	CompanyNPS Pharmaceuticals, Inc	Physical AppearanceClear, colorless to light-straw–colored liquid.	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetGlucagon-like peptide 2 receptor
ID1634	ThPPIDTh1140	NameInsulin, Isophane Or Nph Insulin (Neutral Protamine Hagedorn)	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovolin N	CompanyNovo Nordisk	Physical AppearanceNovolin N InnoLet (nph, human insulin isophane suspension 3 ml disposable prefilled syringe)	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1635	ThPPIDTh1141	NameEpoetin Zeta	Peptide SequenceAPPRLICDSRVLERYLLEAK Full view	Length166	Functional ClassificationIb	DiseaseCancer	BrandRetacrit	CompanyNorbitec	Physical Appearancesolution for injection	Route of AdministartionN.A.	CategoryN.A.	TargetErythropoietin receptor
ID1655	ThPPIDTh1151	NameSomatotropin Recombinant	Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view	Length192	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandNutropinAQ	CompanyGenentech Inc.	Physical AppearanceSterile, white lyophilized powder intended for subcutaneous administration after reconstitution with Bacteriostatic Water	Route of AdministartionSubcutaneous administration	CategoryHormone Replacement Agents	TargetGrowth hormone receptor, Prolactin receptor
ID1656	ThPPIDTh1151	NameSomatotropin Recombinant	Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view	Length192	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandBioTropin	CompanyBio-Technology General (Israel) Ltd.	Physical AppearanceSterile, white, lyophilized powder	Route of AdministartionSubcutaneous administration	CategoryHormone Replacement Agents	TargetGrowth hormone receptor, Prolactin receptor
ID1657	ThPPIDTh1151	NameSomatotropin Recombinant	Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view	Length192	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandProtropin	CompanyGenentech Inc.	Physical AppearanceSterile, white, lyophilized powder	Route of AdministartionIntramuscular or subcutaneous administration	CategoryHormone Replacement Agents	TargetGrowth hormone receptor, Prolactin receptor
ID1659	ThPPIDTh1152	NameDrotrecogin alfa	Peptide SequenceHeavy Chain: LIDGKMT Full view	Length402	Functional ClassificationIb	DiseaseInfectious	BrandXigris	CompanyEli Lilly and Company	Physical AppearanceSterile, lyophilized, white to off-white powder	Route of AdministartionIntravenous Infusion	CategoryAntisepsis	TargetCoagulation factor VIII, V, Plasminogen activator inhibitor 1, Thrombomodulin, Vitamin K-dependent protein S, Ceruloplasmin, Prothrombin, Platelet factor 4, Plasma serine protease inhibitor, Serpin B6, Vitamin K-dependent gamma-carboxylase, Endothelial protein C receptor
ID1661	ThPPIDTh1153	NameAlefacept	Peptide SequenceHeavy Chain: CFSQQIY Full view	Length705	Functional ClassificationIIa	DiseaseImmunological	BrandAmevive	CompanyAstellas Pharma Inc.	Physical AppearanceSterile, white-to-off-white, preservative-free, lyophilized powder	Route of AdministartionIntramuscular Injection	CategoryDermatologic and Immunosupressive agents	TargetT-cell surface antigen CD2, Complement C1r subcomponent, Complement C1q subcomponent subunit A, B, C, Low affinity immunoglobulin gamma Fc region receptor III-A,III-B, II-a, II-b, II-c
ID1662	ThPPIDTh1154	NameOspA lipoprotein	Peptide SequenceMKKYLLGIGLILALIACKQN Full view	Length272	Functional ClassificationIIIa	DiseaseInfectious	BrandLymerix	CompanySmithKline Beecham	Physical AppearanceSterile suspension	Route of AdministartionIntramuscular Injection	CategoryVaccines	TargetToll-like receptor 2
ID1663	ThPPIDTh1155	NameUrokinase	Peptide SequenceKPSSPPEELKFQCGQKTLRP Full view	Length276	Functional ClassificationIb	DiseaseHaemetological	BrandKinlytic	CompanyN.A.	Physical AppearanceSterile lyophilized white powder	Route of AdministartionIntravenous infusion	CategoryN.A.	TargetPlasminogen,Urokinase plasminogen activator surface receptor, Urokinase-type plasminogen activator, Tissue-type plasminogen activator, Plasminogen activator inhibitor 1, 2, Plasma serine protease inhibitor, Low-density lipoprotein receptor-related protein 2, Suppressor of tumorigenicity 14 protein, Nidogen-1
ID1664	ThPPIDTh1156	NameAbarelix	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIIc	DiseaseHormonal	BrandPlenaxis	CompanySpeciality european pharma	Physical AppearanceWhite to off-white sterile dry powder	Route of AdministartionIntramuscular Injection	CategoryAnti-Testosterone Agents	TargetGonadotropin-releasing hormone receptor